Cargando…
Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
Current influenza vaccines stimulate neutralising antibody to the haemagglutinin antigen but as there is antigenic drift in HA it is difficult to prepare a vaccine in advance against an emergent strain. A potential strategy is to induce CD8(+) and CD4(+) T cells that recognize epitopes within intern...
Autores principales: | Powell, Timothy J., Peng, Yanchun, Berthoud, Tamara K., Blais, Marie-Eve, Lillie, Patrick J., Hill, Adrian V. S., Rowland-Jones, Sarah L., McMichael, Andrew J., Gilbert, Sarah C., Dong, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643913/ https://www.ncbi.nlm.nih.gov/pubmed/23658773 http://dx.doi.org/10.1371/journal.pone.0062778 |
Ejemplares similares
-
Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza
Vaccine, MVA-NP+M1, in Humans
por: Lillie, Patrick J., et al.
Publicado: (2012) -
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
por: Berthoud, Tamara K., et al.
Publicado: (2011) -
A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
por: Antrobus, Richard D., et al.
Publicado: (2012) -
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
por: Folegatti, Pedro M., et al.
Publicado: (2019) -
A phase IIb study to determine the safety and efficacy of candidate
INfluenza
Vaccine MVA-NP+M1 in combination with licensed
Ina
CTivated infl
Uenza vaccine in adult
S aged 65 years and above (INVICTUS): a study protocol
por: Swayze, Hannah, et al.
Publicado: (2019)